first glp 1 agonist Victoza: The Generic GLP-1 Receptor Current Insights, Advantages and Challenges

The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes

Adherence to Treatment: Consistent use of Mounjaro as prescribed is crucial for maximizing its effectiveness

Cell and Tissue Research, 372 (1), 9198

It's the first 'to directly compare the efficacy and safety of two oral GLP-1 receptor agonists in a randomised controlled trial', reports Medscape. The part about 'directly comparing' the two drugs is important

The onset of GLP-1RA treatment can lead to Pso flare-ups in some patients, which indicates differences in how individuals immune systems respond to the medication [58,66]